Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

EuroFlow-Based Flowcytometric Diagnostic Screening and Classification of Primary Immunodeficiencies of the Lymphoid System

JJM. van Dongen, M. van der Burg, T. Kalina, M. Perez-Andres, E. Mejstrikova, M. Vlkova, E. Lopez-Granados, M. Wentink, AK. Kienzler, J. Philippé, AE. Sousa, MC. van Zelm, E. Blanco, A. Orfao,

. 2019 ; 10 (-) : 1271. [pub] 20190613

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20028895

Guidelines for screening for primary immunodeficiencies (PID) are well-defined and several consensus diagnostic strategies have been proposed. These consensus proposals have only partially been implemented due to lack of standardization in laboratory procedures, particularly in flow cytometry. The main objectives of the EuroFlow Consortium were to innovate and thoroughly standardize the flowcytometric techniques and strategies for reliable and reproducible diagnosis and classification of PID of the lymphoid system. The proposed EuroFlow antibody panels comprise one orientation tube and seven classification tubes and corresponding databases of normal and PID samples. The 8-color 12-antibody PID Orientation tube (PIDOT) aims at identification and enumeration of the main lymphocyte and leukocyte subsets; this includes naïve pre-germinal center (GC) and antigen-experienced post-GC memory B-cells and plasmablasts. The seven additional 8(-12)-color tubes can be used according to the EuroFlow PID algorithm in parallel or subsequently to the PIDOT for more detailed analysis of B-cell and T-cell subsets to further classify PID of the lymphoid system. The Pre-GC, Post-GC, and immunoglobulin heavy chain (IgH)-isotype B-cell tubes aim at identification and enumeration of B-cell subsets for evaluation of B-cell maturation blocks and specific defects in IgH-subclass production. The severe combined immunodeficiency (SCID) tube and T-cell memory/effector subset tube aim at identification and enumeration of T-cell subsets for assessment of T-cell defects, such as SCID. In case of suspicion of antibody deficiency, PIDOT is preferably directly combined with the IgH isotype tube(s) and in case of SCID suspicion (e.g., in newborn screening programs) the PIDOT is preferably directly combined with the SCID T-cell tube. The proposed ≥8-color antibody panels and corresponding reference databases combined with the EuroFlow PID algorithm are designed to provide fast, sensitive and cost-effective flowcytometric diagnosis of PID of the lymphoid system, easily applicable in multicenter diagnostic settings world-wide.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028895
003      
CZ-PrNML
005      
20210114155308.0
007      
ta
008      
210105s2019 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fimmu.2019.01271 $2 doi
035    __
$a (PubMed)31263462
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a van Dongen, Jacques J M $u Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands.
245    10
$a EuroFlow-Based Flowcytometric Diagnostic Screening and Classification of Primary Immunodeficiencies of the Lymphoid System / $c JJM. van Dongen, M. van der Burg, T. Kalina, M. Perez-Andres, E. Mejstrikova, M. Vlkova, E. Lopez-Granados, M. Wentink, AK. Kienzler, J. Philippé, AE. Sousa, MC. van Zelm, E. Blanco, A. Orfao,
520    9_
$a Guidelines for screening for primary immunodeficiencies (PID) are well-defined and several consensus diagnostic strategies have been proposed. These consensus proposals have only partially been implemented due to lack of standardization in laboratory procedures, particularly in flow cytometry. The main objectives of the EuroFlow Consortium were to innovate and thoroughly standardize the flowcytometric techniques and strategies for reliable and reproducible diagnosis and classification of PID of the lymphoid system. The proposed EuroFlow antibody panels comprise one orientation tube and seven classification tubes and corresponding databases of normal and PID samples. The 8-color 12-antibody PID Orientation tube (PIDOT) aims at identification and enumeration of the main lymphocyte and leukocyte subsets; this includes naïve pre-germinal center (GC) and antigen-experienced post-GC memory B-cells and plasmablasts. The seven additional 8(-12)-color tubes can be used according to the EuroFlow PID algorithm in parallel or subsequently to the PIDOT for more detailed analysis of B-cell and T-cell subsets to further classify PID of the lymphoid system. The Pre-GC, Post-GC, and immunoglobulin heavy chain (IgH)-isotype B-cell tubes aim at identification and enumeration of B-cell subsets for evaluation of B-cell maturation blocks and specific defects in IgH-subclass production. The severe combined immunodeficiency (SCID) tube and T-cell memory/effector subset tube aim at identification and enumeration of T-cell subsets for assessment of T-cell defects, such as SCID. In case of suspicion of antibody deficiency, PIDOT is preferably directly combined with the IgH isotype tube(s) and in case of SCID suspicion (e.g., in newborn screening programs) the PIDOT is preferably directly combined with the SCID T-cell tube. The proposed ≥8-color antibody panels and corresponding reference databases combined with the EuroFlow PID algorithm are designed to provide fast, sensitive and cost-effective flowcytometric diagnosis of PID of the lymphoid system, easily applicable in multicenter diagnostic settings world-wide.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a B-lymfocyty $x imunologie $7 D001402
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a průtoková cytometrie $x metody $7 D005434
650    _2
$a lidé $7 D006801
650    _2
$a imunologická paměť $x imunologie $7 D007156
650    _2
$a kojenec $7 D007223
650    _2
$a novorozenec $7 D007231
650    _2
$a leukocyty $x imunologie $7 D007962
650    _2
$a lymfocyty $x imunologie $7 D008214
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a novorozenecký screening $x metody $7 D015997
650    _2
$a plazmatické buňky $x imunologie $7 D010950
650    _2
$a primární imunodeficience $x diagnóza $x imunologie $7 D000081207
650    _2
$a těžká kombinovaná imunodeficience $x diagnóza $x imunologie $7 D016511
650    _2
$a T-lymfocyty $x imunologie $7 D013601
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a van der Burg, Mirjam $u Department of Immunology, Erasmus MC, Rotterdam, Netherlands. Department of Pediatrics, Leiden University Medical Center, Leiden, Netherlands.
700    1_
$a Kalina, Tomas $u Department of Pediatric Hematology and Oncology, University Hospital Motol, Charles University, Prague, Czechia.
700    1_
$a Perez-Andres, Martin $u Department of Medicine, Cancer Research Centre (IBMCC, USAL-CSIC), Cytometry Service (NUCLEUS), University of Salamanca (USAL), Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), CB/16/12/00233, Instituto Carlos III, Madrid, Spain.
700    1_
$a Mejstrikova, Ester $u Department of Pediatric Hematology and Oncology, University Hospital Motol, Charles University, Prague, Czechia.
700    1_
$a Vlkova, Marcela $u Institute of Clinical Immunology and Allergology, St. Anne's University Hospital Brno, Masaryk University, Brno, Czechia.
700    1_
$a Lopez-Granados, Eduardo $u Department of Immunology, Hospital Universitario La Paz, Madrid, Spain.
700    1_
$a Wentink, Marjolein $u Department of Immunology, Erasmus MC, Rotterdam, Netherlands.
700    1_
$a Kienzler, Anne-Kathrin $u Experimental Medicine Division, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
700    1_
$a Philippé, Jan $u Department of Laboratory Medicine, University Hospital Ghent, Ghent, Belgium.
700    1_
$a Sousa, Ana E $u Faculdade de Medicina, Instituto de Medicina Molecular, Universidade de Lisboa, Lisbon, Portugal.
700    1_
$a van Zelm, Menno C $u Department of Immunology, Erasmus MC, Rotterdam, Netherlands. Department of Immunology and Pathology, Central Clinical School, Alfred Hospital, Monash University, Melbourne, VIC, Australia.
700    1_
$a Blanco, Elena $u Department of Medicine, Cancer Research Centre (IBMCC, USAL-CSIC), Cytometry Service (NUCLEUS), University of Salamanca (USAL), Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), CB/16/12/00233, Instituto Carlos III, Madrid, Spain.
700    1_
$a Orfao, Alberto $u Department of Medicine, Cancer Research Centre (IBMCC, USAL-CSIC), Cytometry Service (NUCLEUS), University of Salamanca (USAL), Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), CB/16/12/00233, Instituto Carlos III, Madrid, Spain.
773    0_
$w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 10, č. - (2019), s. 1271
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31263462 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114155306 $b ABA008
999    __
$a ok $b bmc $g 1609230 $s 1120075
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 10 $c - $d 1271 $e 20190613 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
LZP    __
$a Pubmed-20210105
Zpět

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace